(3.144.202.167)
Users online: 7514     
Ijournet
Email id
 

Research Journal of Pharmacy and Technology
Year : 2022, Volume : 15, Issue : 4
First page : ( 1659) Last page : ( 1663)
Print ISSN : 0974-3618. Online ISSN : 0974-360X.
Article DOI : 10.52711/0974-360X.2022.00277

Coumarins as potential anticoagulant agents

Kumar Abhishek1, Kumar Pankaj2,*, Shravya H.3, Pai Aravind4

1Nitte (Deemed to be University), NGSM Institute of Pharmaceutical Sciences (NGSMIPS)

2Department of Pharmaceutical Chemistry, Mangalore, India

3Manipal Academy of Higher Education, Manipal College of Pharmaceutical Sciences (MCOPS)

4Department of Pharmaceutical Chemistry, Manipal, India

*Corresponding Author E-mail: pankajpgr@nitte.edu.in

Online Published on 08 June, 2022.

Abstract

Major classes of plant metabolites that display a diversity of bioactivities are the Coumarin derivatives. At present, majority of the clinical anti-coagulant agents are coumarins, namely dicoumarol, acenocoumarol and warfarin. The victims who consume coumarins are antidotes should be kept under observation for unfavorable reaction. Phenprocoumon and warfarin, the Vitamin K adversaries, are the front-line oral anti-coagulants for prime and peripheral inhibition of cerebral embolism in victims with atrial fibrillation. Vitamin K adversaries have the capacity of reducing the risk of stroke exceptionally, but their usage is curbed due to some major disadvantages, such as the risk of intracranial and gastrointestinal bleeding, the requirement for systematic laboratory tests for therapy adjustment, interactions with a number of drugs and nutrients, and narrow therapeutic window. At present, latest oral anti-coagulants, namely direct factor Xa inhibitors (e.g., apixaban, rivaroxaban) and direct thrombin inhibitors (e.g., dabigatran), are evolved and tried out in clinical experiments. For the inhibition of cerebral embolism in victims with atrial fibrillation, Rivaroxaban and Dabigatran are currently validated. The role of blood clotting in challenging areas such as the therapeutic potentials of influence over coagulation and the pathogenesis of illness of uncertain etiology shows its biologic and pathologic importance. With growing tempo, acquiring from numerous disciplines - physical, biochemical, physiologic, biochemical, pathologic and clinical, progression has happened swiftly. Adequate proficiency has become handy for over 2 decades in order to grant comprehensive therapeutic requisition. Extensive usage of anti-coagulants and the possibility of their augmentation as vascular and thrombo-embolic sickness have been becoming important as serious medical problems, thereby making re-examination of ample guiding essentials needful.

Top

Keywords

Coumarin, Anti-coagulant, Vitamin K, Blood clotting, Coagulation.

Top

  
║ Site map ║ Privacy Policy ║ Copyright ║ Terms & Conditions ║ Page Rank Tool
740,779,959 visitor(s) since 30th May, 2005.
All rights reserved. Site designed and maintained by DIVA ENTERPRISES PVT. LTD..
Note: Please use Internet Explorer (6.0 or above). Some functionalities may not work in other browsers.